When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ImmunoPrecise Antibodies' (OTCQB:IPATF) subsidiary Talem Therapeutics has entered into a research license agreement with Janssen Research & Development, LLC, providing latter exclusive access to a panel of novel, monoclonal antibodies against an undisclosed target.
More news on: ImmunoPrecise Antibodies Ltd., Healthcare stocks news,